UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,208,000 | -1.5% | 64,788 | -4.6% | 0.06% | 0.0% |
| Q1 2022 | $1,227,000 | +22.8% | 67,905 | +41.0% | 0.06% | +4.9% |
| Q4 2021 | $999,000 | +30.2% | 48,171 | +101.1% | 0.06% | +41.9% |
| Q3 2021 | $767,000 | +95.2% | 23,954 | +87.6% | 0.04% | +104.8% |
| Q2 2021 | $393,000 | -36.4% | 12,768 | -30.4% | 0.02% | -40.0% |
| Q1 2021 | $618,000 | +42.1% | 18,340 | +52.2% | 0.04% | +12.9% |
| Q4 2020 | $435,000 | -55.8% | 12,050 | -55.0% | 0.03% | -3.1% |
| Q3 2020 | $985,000 | -54.2% | 26,753 | -10.9% | 0.03% | +6.7% |
| Q4 2019 | $2,152,000 | +860.7% | 30,025 | +428.3% | 0.03% | +900.0% |
| Q3 2019 | $224,000 | – | 5,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |